15th Annual Immunogenicity for Biotherapeutics
20 Oct 2014 - 22 Oct 2014 - Boston, MA, USA
IIR's 15th Annual Immunogenicity for Biotherapeutics is THE longest running event providing you with a comprehensive overview on predicting and de-risking immune responses from conception to product including pre-clinical, clinical and post clinical phases.
Hear regulatiory updates from the FDA, and 30+ Case Studies from Biogen Idec, Amgen, MedImmune, GlaxoSmithKline, Eli Lilly, Genentec and many more! Plus, global perspectives from Sandoz (Germany), Bayer Healthcare (France), Novo Nordisk (Denmark).
Visit the website to learn more at www.immunogenicityevent.com